In Silico Targeting and Immunological Profiling of PpiA in <i>Mycobacterium tuberculosis</i>: A Computational Approach

Tuberculosis (TB) remains a leading cause of mortality, with drug resistance highlighting the need for new vaccine targets. Peptidyl-prolyl isomerase A (PpiA), a conserved Mycobacterium tuberculosis (Mtb) protein, plays a role in bacterial stress adaptation and immune evasion, making it a potential...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad J. Nasiri, Lily Rogowski, Vishwanath Venketaraman
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/14/4/370
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850143620781309952
author Mohammad J. Nasiri
Lily Rogowski
Vishwanath Venketaraman
author_facet Mohammad J. Nasiri
Lily Rogowski
Vishwanath Venketaraman
author_sort Mohammad J. Nasiri
collection DOAJ
description Tuberculosis (TB) remains a leading cause of mortality, with drug resistance highlighting the need for new vaccine targets. Peptidyl-prolyl isomerase A (PpiA), a conserved Mycobacterium tuberculosis (Mtb) protein, plays a role in bacterial stress adaptation and immune evasion, making it a potential target for immunotherapy. This study uses computational methods to assess PpiA’s antigenicity, structural integrity, and immunogenic potential. The PpiA sequence was retrieved from NCBI and analyzed for antigenicity and allergenicity using VaxiJen, AllerTOP, and AllergenFP. Physicochemical properties were evaluated using ProtParam, and structural models were generated through PSIPRED and SWISS-MODEL. Structural validation was performed with MolProbity, QMEANDisCo, and ProSA-Web. B-cell epitopes were predicted using BepiPred 2.0 and IEDB, while T-cell epitopes were mapped via IEDB’s MHC-I and MHC-II tools. Epitope conservation across Mtb strains was confirmed using ConSurf. Results indicate PpiA is highly antigenic, non-allergenic, and stable, with several immunogenic epitopes identified for both B- and T-cells. This study supports PpiA as a promising immunogenic target for TB vaccine development.
format Article
id doaj-art-212da3d9d36742dabc3f03b267dacbef
institution OA Journals
issn 2076-0817
language English
publishDate 2025-04-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj-art-212da3d9d36742dabc3f03b267dacbef2025-08-20T02:28:38ZengMDPI AGPathogens2076-08172025-04-0114437010.3390/pathogens14040370In Silico Targeting and Immunological Profiling of PpiA in <i>Mycobacterium tuberculosis</i>: A Computational ApproachMohammad J. Nasiri0Lily Rogowski1Vishwanath Venketaraman2Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 19839-69411, IranCollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USACollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766-1854, USATuberculosis (TB) remains a leading cause of mortality, with drug resistance highlighting the need for new vaccine targets. Peptidyl-prolyl isomerase A (PpiA), a conserved Mycobacterium tuberculosis (Mtb) protein, plays a role in bacterial stress adaptation and immune evasion, making it a potential target for immunotherapy. This study uses computational methods to assess PpiA’s antigenicity, structural integrity, and immunogenic potential. The PpiA sequence was retrieved from NCBI and analyzed for antigenicity and allergenicity using VaxiJen, AllerTOP, and AllergenFP. Physicochemical properties were evaluated using ProtParam, and structural models were generated through PSIPRED and SWISS-MODEL. Structural validation was performed with MolProbity, QMEANDisCo, and ProSA-Web. B-cell epitopes were predicted using BepiPred 2.0 and IEDB, while T-cell epitopes were mapped via IEDB’s MHC-I and MHC-II tools. Epitope conservation across Mtb strains was confirmed using ConSurf. Results indicate PpiA is highly antigenic, non-allergenic, and stable, with several immunogenic epitopes identified for both B- and T-cells. This study supports PpiA as a promising immunogenic target for TB vaccine development.https://www.mdpi.com/2076-0817/14/4/370tuberculosis vaccinepeptidyl-prolyl isomerase A (PpiA)immunoinformaticepitope predictionB-cell epitopesT-cell epitopes
spellingShingle Mohammad J. Nasiri
Lily Rogowski
Vishwanath Venketaraman
In Silico Targeting and Immunological Profiling of PpiA in <i>Mycobacterium tuberculosis</i>: A Computational Approach
Pathogens
tuberculosis vaccine
peptidyl-prolyl isomerase A (PpiA)
immunoinformatic
epitope prediction
B-cell epitopes
T-cell epitopes
title In Silico Targeting and Immunological Profiling of PpiA in <i>Mycobacterium tuberculosis</i>: A Computational Approach
title_full In Silico Targeting and Immunological Profiling of PpiA in <i>Mycobacterium tuberculosis</i>: A Computational Approach
title_fullStr In Silico Targeting and Immunological Profiling of PpiA in <i>Mycobacterium tuberculosis</i>: A Computational Approach
title_full_unstemmed In Silico Targeting and Immunological Profiling of PpiA in <i>Mycobacterium tuberculosis</i>: A Computational Approach
title_short In Silico Targeting and Immunological Profiling of PpiA in <i>Mycobacterium tuberculosis</i>: A Computational Approach
title_sort in silico targeting and immunological profiling of ppia in i mycobacterium tuberculosis i a computational approach
topic tuberculosis vaccine
peptidyl-prolyl isomerase A (PpiA)
immunoinformatic
epitope prediction
B-cell epitopes
T-cell epitopes
url https://www.mdpi.com/2076-0817/14/4/370
work_keys_str_mv AT mohammadjnasiri insilicotargetingandimmunologicalprofilingofppiainimycobacteriumtuberculosisiacomputationalapproach
AT lilyrogowski insilicotargetingandimmunologicalprofilingofppiainimycobacteriumtuberculosisiacomputationalapproach
AT vishwanathvenketaraman insilicotargetingandimmunologicalprofilingofppiainimycobacteriumtuberculosisiacomputationalapproach